Spring 2024 Vol. 14 Issue 01
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Tending Your GardenRemove those things that will hamper your growth during cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
An Extra Set of Eyes and EarsCaregivers’ unique perspectives can enrich conversations with doctors, but it’s not always easy to decide when to speak up.
by K.J. Bannan
-
Policy Matters
Cancer Research Funding Faces Uncertain FutureThe AACR is planning numerous initiatives in 2024 to bolster congressional support.
by Jon Retzlaff, MBA, MPA
-
A Gentler Treatment Course
Patients who speak up when they don’t feel well can help doctors manage side effects caused by chemotherapy.
by Marci A. Landsmann
-
Taking a Shot Against Cancer Recurrences
Early findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.
by Kendall K. Morgan
-
Climate Change and Cancer Care
Cancer centers and their patients face disruptions caused by hurricanes, wildfires and other extreme weather events.
by Cameron Walker
-
Survivor Profile
An Inspiration to OthersKay Kays, a 30-year pancreatic cancer survivor, works to advance research and raise awareness of the disease.
by Lindsey Konkel Neabore
-
Q&A
A Musical Takes on CancerMusician and breast cancer survivor Marcy Marxer reenacts life during cancer treatment, with a comedic twist.
by Tyler Santora
-
Get Involved
Creating ConnectionsChemo Companions ensures people with cancer do not have to be alone during their chemotherapy treatments.
by Thomas Celona
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles